Abiopharma

🔍 Benson James M (Executive)

Company: Dynatrace, Inc. (DT)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Acquired 17,731 shares of Common Stock (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 184,817.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 8,573 shares of Common Stock at $41.19 per share (Direct)
  Date: 2026-06-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 176,244.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 17,731 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 35,464.00 | transaction_form_type: 4 | Footnotes: F1, F3, F1

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date.
• F2: Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations upon the vesting of RSUs.
• F3: Represents the vesting of RSUs granted on December 15, 2022 under the Issuer's 2019 Equity Incentive Plan, as amended. 25% of the RSUs granted vested on December 15, 2023 and the balance of the RSUs vest in equal quarterly installments thereafter until fully vested on December 15, 2026, subject to the Reporting Person's continued employment on the applicable vesting dates.